. 2022 Jul 5;12:11380. doi: 10.1038/s41598-022-15778-3

Table 2.

Colorectal cancer screening rates for the period 2018–2020.

Characteristics	2018 (n = 2277^a)	2019 (n = 2425^a)	2020 (n = 2467^a)	2019 versus 2018			2020 versus 2019
Characteristics	SR, %^b	SR, %^b	SR, %^b	SE	SRR	95% CI	SE	SRR	95% CI
Overall	20.0	19.1	14.8	0.029	0.95	0.90–1.01	0.029	0.77	0.73–0.82
Age group, years
50–59	23.4	19.3	16.1	0.041	0.82	0.76–0.89	0.042	0.83	0.77–0.91
60–69	16.7	20.5	14.0	0.050	1.23	1.11–1.35	0.049	0.68	0.62–0.75
70–74	14.7	16.1	13.0	0.077	1.09	0.94–1.27	0.065	0.81	0.71–0.92
Sex
Male	17.2	19.3	14.9	0.042	1.12	1.03–1.22	0.041	0.77	0.71–0.83
Female	22.8	18.9	14.7	0.041	0.83	0.77–0.90	0.040	0.78	0.72–0.84
Residential area
Metropolitan	21.3	20.1	12.3	0.044	0.94	0.86–1.02	0.043	0.62	0.57–0.67
Urban	20.1	19.3	18.4	0.045	0.96	0.88–1.05	0.043	0.95	0.87–1.03
Rural	15.8	15.0	10.5	0.080	0.95	0.81–1.11	0.083	0.70	0.59–0.82
Monthly household income ($)
≤ 3999	16.5	19.3	13.4	0.044	1.17	1.08–1.28	0.043	0.69	0.64–0.75
4000–6999	22.3	16.7	15.0	0.052	0.75	0.68–0.83	0.053	0.89	0.81–0.99
≥ 7000	23.5	21.6	16.9	0.059	0.92	0.82–1.03	0.056	0.78	0.70–0.87
Education status
Middle school or lower	15.0	15.1	13.5	0.062	1.01	0.89–1.14	0.061	0.89	0.79–1.01
High school	20.1	19.6	14.4	0.038	0.97	0.90–1.05	0.037	0.73	0.68–0.79
College or higher	24.9	22.8	17.6	0.067	0.91	0.80–1.04	0.067	0.77	0.68–0.88
Chronic disease^c
No	20.3	19.4	13.5	0.042	0.96	0.88–1.04	0.042	0.70	0.64–0.75
Yes	19.8	18.8	15.9	0.041	0.95	0.88–1.03	0.039	0.84	0.78–0.91

SR screening rate, SRR screening rate ratio, SE standard error, CI confidence interval.

^aThe n value is the number of individuals eligible for colorectal cancer screening (aged over 50 years); ^bSRs were defined as the proportion of screened individuals within the last 1 year; Weighting values from the Population and Housing Census were applied to calculate the SRs; ^cChronic disease, individuals who are diagnosed with any of following diseases: hypertension, diabetes, tuberculosis, hepatitis B, hepatitis C, liver cirrhosis, chronic gastritis, stomach/duodenal ulcers, polyps, benign breast diseases, uterine myoma, and hyperlipidemia.